May 16, 2012 – Silicon Bayou News
NuMe Health, the New Orleans-based biotech startup developing products that modify the bacteria that live in the gastrointestinal tract, today announced that it has closed a $1.5 million Series A financing.
NuMe Health Lands 1.5m Series A
Related Articles
Webinar | IP Basics for Startups 2026 | Wed April 29
Are you a founder or work for a startup? Do you want to sharpen your IP knowledge and skills? Join us for IP Basics for Startups in 2026, a webinar…
Beken Bio Announces Lab Expansion at New Orleans BioInnovation Center
FOR IMMEDIATE RELEASE Beken Bio Announces Lab Expansion at New Orleans BioInnovation Center, advancing ovarian cancer detection efforts New CLIA-certified lab marks milestone toward commercialization of breakthrough blood test NEW…
CDVCA and New Orleans BioFund co-invest to advance bioscience innovation and economic opportunity in New Orleans
For Immediate Release CDVCA and New Orleans BioFund co-invest to advance bioscience innovation and economic opportunity in New Orleans NEW ORLEANS (March 3, 2026) — The Community Development Venture Capital Alliance…